Insperity stock inched up about 1.6% today, adding a little calm to what has been a choppy year for investors trying to read this human resources outsourcer. The relief comes from one clear headline: profit pressure finally eased a bit. Adjusted earnings per share landed at $0.34 and adjusted earnings before interest, tax, depreciation and amortisation reached $36 million, both ahead of the company’s own midpoints.

That short term beat matters, but the real story for Insperity now is whether this early margin recovery can rebuild confidence in a business that is still loss making on a trailing twelve month basis.

Love the early margin relief at Insperity but concerned it is still loss making on a trailing twelve month basis? Check out our 89 resilient stocks with low risk scores for ideas that combine steadier earnings profiles with lower risk scores.

Q2 2026 Earnings Summary

• Revenue (Q2 2026 vs Q2 2025): US$1,686 million vs. US$1,658 million (up about 1.7%)
• Net Income/Loss (Q2 2026 vs Q2 2025): Net income of US$4 million vs. a loss of US$5 million (returned to profit)
• Basic EPS (Q2 2026 vs Q2 2025): US$0.10 vs. a loss of US$0.13 per share (swung back to positive EPS)
• Trailing Twelve Month Net Result (Q2 2026 vs Q2 2025 TTM): Net loss of US$16 million vs. net income of US$40 million (moved from profit to loss on a trailing basis)

Prefer clear visuals instead of another block of earnings tables and commentary? See Insperity’s overall valuation picture at a glance with interactive charts and a full visual breakdown in our company report for Insperity.

Insperity bull case hinges on margin reset proof

Bulls argue Insperity is in a margin reset that will restore earnings power as pricing, benefit design and HRScale scale through the model. Q2 gives some support. Adjusted EBITDA grew 13% year on year to US$36m and adjusted EPS rose 31% to US$0.34, both above midpoints, which fits the idea of early operating leverage. Operating expenses fell 8% and cash OpEx declined 6%, showing cost discipline rather than just softer comps. Management also held paid worksite employees close to flat, down only 1.1% and above guidance, which suggests pricing changes are not driving severe client erosion. HRScale is moving from slideware to contracts, with about 8,000 worksite employees sold and early terms described as favorable. For the bullish narrative, Q2 marks progress, although gross profit per employee is still slightly lower year on year, so the reset is not yet fully proven.

Bear case tests: health costs, growth drag, HRScale risk

Bears focus on three points: health care costs may stay volatile, growth could stall and HRScale might become an expensive distraction. Q2 does not clear those concerns. Benefits cost per covered employee increased 5.2% while gross profit per worksite employee slipped 1% and total gross profit declined 3%. That aligns with the fear that pricing and plan tweaks are only partly catching up with medical inflation. Insperity still reports a trailing twelve month net loss of US$16m compared with prior year profit, so earnings fragility is visible. Guidance also flags risk. Management widened ranges and still expects paid worksite employees to fall about 1% to 1.6% for 2026. That reinforces the view that margin repair is coming with some growth drag. HRScale traction is early and requires more scale to counter the bear argument about long and uncertain payback.

After margin compression, health care volatility and a still fragile profit picture, you may want to review our risk analysis for Insperity which shows 1 important warning sign

Stay Ahead With Simply Wall St

If the early margin recovery at Insperity has your attention but the trailing twelve month loss keeps you cautious, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and wait for a setup that fits your plan. After you decide to take a position, keep your focus on the signal rather than the noise through the Portfolio Command Center which highlights the most important changes to your holdings. For a longer term view, tap into crowd insights and see how other investors are thinking through Insperity and similar stocks inside the Community. This way you can spot potential catalysts and risks earlier and stay a step ahead of the market.

Seeking Alternatives Beyond Insperity?

Fresh stock ideas move fast. Some sit under the radar for now, others build quiet momentum before the crowd catches on. Screen them while it matters and get in early.

• Spot companies with pricing power and sturdy balance sheets by scanning a curated list of solid balance sheet and fundamentals stocks (46 results) that can support growth plans through different operating conditions.
• Ride potential breakout themes in automation by reviewing a focused list of 34 robotics and automation stocks positioned to benefit as businesses update workflows and cut manual processes.
• Track where AI spending may be flying next by checking a hand picked group of 56 AI infrastructure stocks supporting the chips, data centers and tools behind the headlines.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.